Provided herein are small molecule activators of Nicotinamide Phosphoribosyltransferase (NAMPT), compositions comprising the compounds, and methods of using the compounds and compositions.

Provided herein are small molecule activators of Nicotinamide Phosphoribosyltransferase (NAMPT), compositions comprising the compounds, and methods of using the compounds and compositions.

Sterile ophthalmic gels of chloroprocaine having improved functionality, pharmacokinetics, and stability, particularly in terms of clarity, and to methods of making and using same.

Sterile ophthalmic gels of chloroprocaine having improved functionality, pharmacokinetics, and stability, particularly in terms of clarity, and to methods of making and using same.

A composition, and method for using the same, for treating a canker sore includes 10-30% of an ester local anesthetic, 0.5-2% of a corticosteroid, and a carrier for the ester local anesthetic and the corticosteroid. The carrier is formulated as a paste so as to be applied topically to the canker sore to deliver the ester local anesthetic and the corticosteroid simultaneously to the canker sore.

A composition, and method for using the same, for treating a canker sore includes 10-30% of an ester local anesthetic, 0.5-2% of a corticosteroid, and a carrier for the ester local anesthetic and the corticosteroid. The carrier is formulated as a paste so as to be applied topically to the canker sore to deliver the ester local anesthetic and the corticosteroid simultaneously to the canker sore.

The present disclosure provides compositions comprising combinations of one or more lectins, sulfated polysaccharides from marine algae, and cannabinoids and a pharmaceutically acceptable excipient or mixtures of excipients and methods of preparing such compositions.

The present disclosure provides compositions comprising combinations of one or more lectins, sulfated polysaccharides from marine algae, and cannabinoids and a pharmaceutically acceptable excipient or mixtures of excipients and methods of preparing such compositions.

The present embodiments relate to a method of treating dry eyes. The method includes a plurality of visits to an eye doctor with each even numbered visit focused on a first eye and each odd numbered visit focused on a second eye. The plurality of visits comprises use of intense pulsed light (“IPL”) therapy, low level light therapy, an ocular nebulizer, dehydrated amniotic membranes, biologic eye drops, advanced lubricants, eyelid debridement, meibomian gland imaging and a slit lamp.

The present embodiments relate to a method of treating dry eyes. The method includes a plurality of visits to an eye doctor with each even numbered visit focused on a first eye and each odd numbered visit focused on a second eye. The plurality of visits comprises use of intense pulsed light (“IPL”) therapy, low level light therapy, an ocular nebulizer, dehydrated amniotic membranes, biologic eye drops, advanced lubricants, eyelid debridement, meibomian gland imaging and a slit lamp.